NCT00114023已完成不适用
A Follow-up Study to Evaluate Actinic Keratosis Recurrence Rates One Year After Completion of the 1473-IMIQ Study
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 84
研究概览
简要总结
This is a 1-year follow-up study to evaluate the long-term effects in subjects who completely cleared their actinic keratosis (AK) lesions in the 1473-IMIQ study. The 1473-IMIQ study evaluated the safety and effectiveness of imiquimod 5% cream compared to a placebo cream for the treatment of AK.
研究设计
- 研究类型
- Observational
- 观察模型
- Defined Population
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Subject had to participate in the 1473-IMIQ Study AND have had 100% clearance of AK lesions
排除标准
- •Did not use any topical preparations in the previous treatment area within 24-hours of the scheduled visit.
研究者
相似试验
终止
3 期
A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier StudyKeratosis, ActinicNCT04269395Galderma R&D125
已完成
不适用
A Study to Follow up Recurrence Rates of Actinic Keratoses One Year After Completion of Study 1487-IMIQActinic KeratosesNCT00189254MEDA Pharma GmbH & Co. KG72
终止
不适用
Observational Trial Tolerability and Efficacy of Resiquimod Gel in Patients Treated for Actinic Keratosis.Actinic KeratosisNCT01806961Spirig Pharma Ltd.16
终止
4 期
Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic TherapyActinic KeratosisNCT01203878Tennessee Clinical Research Center21
已完成
不适用
A Long Term Follow up Study of Patients Who Have Completed the PEP005-020 StudyActinic KeratosisNCT00952783Peplin98